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Epigenetic DNA Demethylation
Causes Inner Ear Stem Cell
Differentiation into Hair Cell-Like
Cells
Yang Zhou and Zhengqing Hu*
Department of Otolaryngology-Head and Neck Surgery, Wayne State University School of Medicine, Detroit, MI, USA
The DNA methyltransferase (DNMT) inhibitor 5-azacytidine (5-aza) causes genomic
demethylation to regulate gene expression. However, it remains unclear whether 5-aza
affects gene expression and cell fate determination of stem cells. In this study, 5-aza was
applied to mouse utricle sensory epithelia-derived progenitor cells (MUCs) to investigate
whether 5-aza stimulated MUCs to become sensory hair cells. After treatment,
MUCs increased expression of hair cell genes and proteins. The DNA methylation
level (indicated by percentage of 5-methylcytosine) showed a 28.57% decrease after
treatment, which causes significantly repressed DNMT1 protein expression and DNMT
activity. Additionally, FM1-43 permeation assays indicated that the permeability of
5-aza-treated MUCs was similar to that of sensory hair cells, which may result from
mechanotransduction channels. This study not only demonstrates a possible epigenetic
approach to induce tissue specific stem/progenitor cells to become sensory hair
cell-like cells, but also provides a cell model to epigenetically modulate stem cell fate
determination.
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INTRODUCTION
In mammals, inner ear sensory hair cell damage is a major health problem causing deafness or
hearing impairments to ∼10% of the population, which are usually induced by loud sound, aging,
aminoglycoside drug exposure, diseases, and genetic disorders (Basner et al., 2015; Parker and
Bitner-Glindzicz, 2015; Wong and Ryan, 2015). Previous studies revealed that non-mammalian
vertebrates have the capability to repair injured sensory hair cells; however, this self-repair ability is
severely limited in mammals (Jia et al., 2009; Oesterle, 2013). Recent studies suggest that stem cells
may be a possible cell source for mammalian sensory hair cell regeneration (Okano and Kelley,
2012; Ronaghi et al., 2012). For instance, mouse embryonic stem cells have been induced to non-
neural ectoderm, preplacodal ectoderm, and otic vesicle epithelia, which eventually develop into
cell clusters containing hair cells and supporting cells (Koehler and Hashino, 2014). Tissue specific
stem/progenitor cells have been isolated from adult mouse utricle sensory epithelia and expressed
markers shown in prosensory cells, which are hair cell stem cells during otic vesicle development.
Abbreviations:MUC, adult mouse utricle sensory epithelial derived progenitor cells; 5-aza, 5-azacytidine; MeDIP, methylated
DNA immunoprecipitation; MSP, Nested-methylation-specific PCR.
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These inner ear stem/progenitor cells have shown the capability
to differentiate into cells expressing hair cell genes Myo7a and
Pou4f3 (Kelley, 2006; Savary et al., 2007; Koehler and Hashino,
2014). Our previous study has demonstrated that adult mouse
utricle sensory epithelial cells are able to become prosensory-
like cells (MUCs; Zhang and Hu, 2012), which express the
genes that are shown in hair cell progenitor cells (Kelley, 2006),
suggesting that MUCs may be a valuable cell source to study
mammalian hair cell regeneration. For the purpose of future
clinical applications to replace human sensory hair cells, it is
ideal to guide stem cells to become sensory hair cells without
changing DNA sequence. However, it remains unclear how to
efficiently achieve this research aim and the mechanism critical
for cell differentiation is still obscure.
DNA methylation/demethylation is one of the major
epigenetic modifications to regulate gene expression without
changing DNA sequence (Jones and Takai, 2001; Jaenisch and
Bird, 2003). DNA methylation is a process of adding methyl
group to 5-cytosine catalyzed by DNA methyltransferase
(DNMT). In mammals, DNMT family has three major members
including DNMT1, DNMT3a, and DNMT3b. DNMT1 is
responsible for maintenance of methylation pattern through
DNA replication, whereas DNMT3a and DNMT3b take charge
of the de novo DNA methylation. DNA methylation by addition
of methyl group to the promoter sequence leads to gene silence,
whereas DNA demethylation by removing methyl group from
the promoter region of the silenced gene stimulates gene
expression (Sanz et al., 2010; Guo et al., 2014). For example,
DNA methylation inhibits gene expression in a hematopoietic
stem cell line OCI-AML3 by adding methyl groups to the
promoter region and transcription start site. However, DNA
demethylation of OCI-AML3 activates gene expression by
decreasing the genomic methylation level (Lund et al., 2014).
It has been reported that DNA demethylation is involved in
lineage specification in mouse neural stem cells (Wheldon
et al., 2014) and reprogramming of mouse somatic cells into
pluripotent stem cells (Chen et al., 2015). These pioneer studies
suggest that DNA demethylation plays a critical role in stem
cell fate determination. However, previous reports have only
studied the relationship between DNA demethylation and gene
expression. It is still unclear whether DNA demethylation is
able to stimulate the differentiation of stem cells, trigger the
expression of differentiation proteins and generate functional
differentiated cells.
In our previous study, we treated MUCs with the DNMT
inhibitor 5-aza-2′-deoxycytidine (5-aza-CdR) and found that
the genomic methylation level was significantly decreased
(Zhou and Hu, 2015). 5-aza-CdR treated MUCs increased
expression of epithelial genes, hair cell genes, and prosensory
genes. However, 5-aza-CdR did not significantly affect the
protein expression of epithelial sensory hair cell markers
E-cadherin, Cytokeratin, Myosin VI, and Myosin VIIa,
which may be a possible explanation for incomplete hair
cell differentiation. Moreover, expression of DNMT1 gene
was not significantly changed after 5-aza-CdR treatment.
Therefore, additional study and alternative approaches are
necessary to guide MUCs to undergo a more complete hair
cell differentiation at the protein expression and functional
levels.
It has been reported that 5-aza-CdR can only incorporate into
DNA and irreversibly binds to DNMT to reduce the addition of
methyl groups to DNA (Liyanage et al., 2013; Hackanson and
Daskalakis, 2014). There is no evidence showing that 5-aza-CdR
has direct effects on protein expression. 5-azacytidine (5-aza)
is another DNA methyltransferase inhibitor, which is able to
incorporate into both genomic DNA and RNA (Aimiuwu et al.,
2012; Borodovsky et al., 2013). The incorporation of 5-aza into
DNA shares the similar mechanism of 5-aza-CdR incorporation
into DNA. However, 5-aza is primarily incorporated into RNA
rather than DNA, by which triggers polyribosome disassembly
and defective methylation of transfer RNA, and repress DNMT
protein production (Schneider-Stock et al., 2005; Chen et al.,
2013). 5-aza has been used to regulate expression of tumor
suppressor gene in myelodysplastic syndromes (MDS) and acute
myeloid leukemia (AML; Kimura et al., 2012; Orskov et al.,
2015), and it has been applied to stem cell research (Rosca
and Burlacu, 2011). For instance, 5-aza causes considerable
demethylation in the promoter region of osteogenic specific
genes, and stimulates mouse bone marrow derived mesenchymal
stem cells to differentiate into osteoblasts (Zhou et al., 2009).
Additionally, 5-aza regulates expression of bone morphogenetic
protein-4 (BMP4) in mouse pluripotent stem cells, which
induces adipocyte lineage differentiation (Bowers et al., 2006).
These studies suggest that 5-aza may affect the methylation
level of stem/progenitor cells to influence stem cell fate
determination.
DNA demethylating agents including the DNMT inhibitor
5-aza work best on proliferating cells; therefore, we apply 5-
aza to proliferating cell lines such as MUCs in this study. We
aimed to investigate whether 5-aza would be able to affect
genomic methylation level to stimulate the expression of sensory
hair cell genes and proteins. Moreover, we planned to explore
the molecular mechanism underlying 5-aza-caused hair cell
differentiation using genomic methylation quantification, nested
methylation specific PCR (nested-MSP) targeting the promoter
region of studied genes, methylated DNA immunoprecipitation
(MeDIP), and DNMT activity assays.
MATERIALS AND METHODS
Cell Culture and DNA Demethylation
Treatment
Mouse utricle sensory epithelia-derived progenitor cell lines
(MUC), which have been established in our previous study
(Zhang and Hu, 2012), were used in this study. MUCs were
cultured in DMEM/F12 GlutaMAXTM with 10% fetal bovine
serum (FBS, all from Invitrogen) in an incubator supplied with
5% CO2 at 37
◦C (Zhang and Hu, 2012). 5-azacytidine (5-aza,
Sigma) was applied to MUC when the cell confluence reached
40–50%. MUCs in the control group were cultured in the culture
medium in the absence of 5-aza. Control and treated MUCs
were observed daily using phase contrast microscopy and images
were captured using a digital camera. MUCs were treated with
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5-aza for 5 days, and MUCs were passaged when cell confluence
reached 70–80%.
Viability Assay
To test the cytotoxicity of 5-aza, MUCs were exposed to 20,
40, 80, 160, and 320 µM of 5-aza for 48 h. In the control
group, MUCs were kept in the medium containing vehicle
(DMEM/F12). After 48 h of 5-aza treatment, 2 µM calcein AM,
and 0.3 µg/ml propidium iodide (PI, both from Invitrogen)
were added to culture medium for 30 min, followed by Hoechst
33,342 (10 µg/ml, Invitrogen) staining to label nuclei. MUCs
were observed by epifluorescence microscopy with a cooled CCD
camera (n = 5/group). One-way analysis of variance (ANOVA)
and Tukey’s post-hoc test were used for analysis and P < 0.05
was determined as the criterion of statistical significance in this
study.
RNA Extraction, Reverse Transcription
PCR (RT-PCR), and Real Time Quantitative
RT-PCR (Quantitative PCR)
After 5 days of 5-aza treatment, total RNA was extracted
from the control and treated MUCs with an RNeasy Mini Kit
(Qiagen), followed by cDNA conversion using a QuantiTect
Reverse Transcription Kit (Qiagen) according to manufacturers’
protocols. A thermal cycler (Eppendorf) was used for RT-PCR
with GoTaq R© Green Master Mix (Promega) and primers in
Table 1. PCR products were electrophoresed and imaged using
a ChemiDoc-It R© 2 imaging system (UVP).
TABLE 1 | Primers used in RT-PCR, quantitative PCR, Nested-MSP and MeDIP-quantitative PCR.
Gene Forward: 5′-3′ Reverse: 5′-3′ Product length (bp)
Gapdh GGCCGCATCTTCTTGTGCAGT TGCAAATGGCAGCCCTGGTGA 111
Cdh1 ATTCAAAGTGGCGACAGACGGC ACCTGGGTACACGCTGGGAAACAT 223
Krt8 CAAGGTGGAACTAGAGTCCCG CTCGTACTGGGCACGAACTTC 187
Snai1 ATGCACATCCGAAGCCACACG TGGAGCAAGGACATGCGGGAGAA 245
Snai2 CATCCTTGGGGCGTGTAAGTC GCCCAGAGAACGTAGAATAGGTC 186
Zeb1 ACTGCAAGAAACGGTTTTCCC GGCGAGGAACACTGAGATGT 127
Zeb2 CCACGCAGTGAGCATCGAA CAGGTGGCAGGTCATTTTCTT 131
Vim AAGCCGAAAGCACCCTGCAGTCAT AGGTCAGGCTTGGAAACGTCCACA 202
Fn1 GTGACACTTATGAGCGCCCTA CCACTTGTCGCCAATCTTGTA 137
Cdh2 ATGCCCTGAATGGAATGCTGCGGT GCTGTGGCTGTGTTTGAAAGGCCA 211
Bmp4 CATGAGGGATCTTTACCGGCTC TCTCCAGATGTTCTTCGTGATGG 140
P27kip1 GCGGTGCCTTTAATTGGGTC TTCGGGGAACCGTCTGAAAC 197
Prox1 TGGAGAAGTATGCGCGTCAA CTGCGCAACTTCCAGGAATC 155
Lfng GCCGTCAAGACCACCAGAAAG GGTCATACTCCACAGCCATCTT 208
Sox2 GCGGAGTGGAAACTTTTGTCC CGGGAAGCGTGTACTTATCCTT 157
Dlx5 CACCACCCGTCTCAGGAATC GCTTTGCCATAAGAAGCAGAGG 125
Notch1 GCGTCACTTGGCAGCCTCAA CACCCCACAGCCCACAAAGA 144
Hes1 AGCACAGAAAGTCATCAAAGCC ATGTCTGCCTTCTCTAGCTTGG 142
Hes5 AGTCCCAAGGAGAAAAACCGA GCTGTGTTTCAGGTAGCTGAC 183
Isl1 ATGATGGTGGTTTACAGGCTAAC TCGATGCTACTTCACTGCCAG 174
Jag1 CCTCGGGTCAGTTTGAGCTG CCTTGAGGCACACTTTGAAGTA 150
Numb CTTCCCAGTTAAGATCCTCGGC CCCGTTGTTCCAAAGAAGCCT 126
Atoh1 CCCGTCCTTCAACAACGACAAG AGGTGATGGTGGTCATTTTTGC 156
Myo7a GCACTTCATCATCGGCAACGGCAT GCTGCTCTTGGATGGGTTGTGTGT 100
Myo6 GGCATCGTCCCAAGAGATTTTC CCACAATGTCAAAGTTCGGTACA 150
Espn CTGCCTGGAGACGAGACATT GCAGCTTCTCCGACTGTTCT 123
Pou4f3 CGCACAACAACATGATCGCT TTCTCGGATGAAGGACGTGG 199
Methylated Cdh1 GTTTTTAGTTAATTAGCGGCGTC ACACTAAACTCGAATACGATCGAA 175
Unmethylated Cdh1 GTTTTTAGTTAATTAGTGGTGTTGG CACTAAACTCAAATACAATCAAA 174
Methylated Atoh1 TATTTTGTAGGCGAGAGATTTTTTC ACTCACCCTAACTATCAACCTCGT 197
Unmethylated Atoh1 TTTTGTAGGTGAGAGATTTTTTTGT AACTCACCCTAACTATCAACCTCAT 196
Methylated Pou4f3 GCGGTTTCGTTTTGTTTTTC GTTCATAACCATCATCTTCGAA 263
Unmethylated Pou4f3 GATTTGTGGTTTTGTTTTGTTTTTT AACATTCATAACCATCATCTTCAAA 271
MeDIP Cdh1 TTTAGTTAGTAAAGGTTAATGGCGG AAACTTTATTCATCATCTAAATTTCCGT 268
MeDIP Atoh1 TTTTTTTGATTGGGTAGATACGC CTCCGATTACTAAAAACGCTACG 117
MeDIP Pou4f3 GCGGTTTCGTTTTGTTTTTC GTTCATAACCATCATCTTCGAA 263
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Quantitative PCR was performed by Bio-Rad CFX system
with SsoAdvanced
TM
SYBR R© Green Supermix (Bio-rad) (n= 3).
The melting temperature and efficiency of primers have been
determined in a previous study (Zhou and Hu, 2015). The
mean quantification cycle (Cq) was calculated by Bio-Rad CFX
Manager software in a regression mode and studied genes with
Cq value >40 was believed no expression and excluded from
statistical analysis. The Cq values of the internal control gene
Gapdh in the control and treated groups that had been calibrated
within one cycle were used as calibrator references for analysis.
The 2−11Cq (Livak) Method (Bio-Rad CFX Manager software)
was used to quantify the fold change of studied genes. In
quantitative analysis, relative mRNA expression change ≥2-fold
was considered to be biologically important and qualified for
statistical analysis, and a two-tailed Student’s t-test was used for
statistical analysis.
Genomic DNA Extraction, Bisulfite
Conversion Reactions, and
Nested-Methylation-Specific PCR
(Nested-MSP)
Genomic DNA (gDNA) was extracted from MUCs from
the control and treatment groups using a Flexi DNA Kit
(Qiagen), followed by a bisulfite conversion reaction using
an EpiTect Bisulfite Conversion Kit (Qiagen) according to
the manufacturer’s protocol. Nested-MSP was used to detect
the methylation pattern of studied genes with a Qiagen
MSP Kit (n = 3). The primers targeting the CpG islands
of promoter regions of studied genes for nested-MSP were
included in Table 1. The products of nested-MSP were analyzed
by electrophoresis and ChemiDoc-It R© 2 imaging system. To
compare the methylation level of studied genes, expression of
unmethylated studied gene was normalized in the control and
treated MUCs.
Methylated DNA Immunoprecipitation
(MeDIP) and Quantitative PCR
Before DNA shearing, gDNA of both control and treated
MUCs were diluted to a final concentration of 100 µg/ml.
Digital sonifier 250 (Branson) was used to shear the gDNA
by 5 pulses of sonication at 205 amplitude for 10 s, followed
by immunoprecipitation using an EpiQuik
TM
Methylated
DNA Immunoprecipitation Kit (Epigenetek) according to the
manufacturer’s protocol. The same amount of gDNA fragments
from the control and treatment groups was added to the
immunoprecipitation reaction. Quantitative PCR was used to
quantitatively evaluate the amount of methylated gene using the
same amount of MeDIP product templates of the control and
treatment MUCs (n = 3). The primers targeting the CpG islands
of promotor regions of studied genes for MeDIP quantitative
PCR were shown in Table 1. Quantitative amount of methylated
gene was described by the mean quantification cycle (Cq),
which was calculated by Bio-Rad CFX Manager software. In
this study, the mean Cq value change ≥1 cycle (which means
at least two-fold expression changes) was considered to be
of biomedical importance. The fold change of studied genes
(11Cq) was calculated using the 2−11Cq (Livak) Method
(Bio-Rad CFX Manager software). A two-tailed Student’s t-test
was used to compare the mean Cq values of studied genes
between the control and treatment groups. Cq values >40 were
not considered to have significant gene expression thus excluded
from statistical analysis.
Immunofluorescence
After 5 days of 5-aza treatment, control and treated MUCs were
fixed in 4% paraformaldehyde for 10 min at room temperature,
followed by incubation in PBS containing 5% donkey serum
(Jackson Immunoresearch), and 0.2% Triton X-100 (Sigma)
for 20 min. Primary antibodies included epithelial markers
anti-E-cadherin (1:200; Santa Cruz) and anti-pan-cytokeratin
26 (PCK26; 1:100; Sigma), and hair cell markers anti-Myosin
VI (Myo6; 1:200; Sigma), anti-Myosin VIIa (Myo7a; 1:200;
DSHB), anti-Math1 (Atoh1; 1:200; DSHB), anti-Pou4f3 (1:200;
Sigma), anti-Espin (1:100; a gift from Dr. James Richard Bartles,
Northwestern University), anti-DNMT1 (1:100; Epigentek) and
anti-PCNA (1:100; Abcam). Secondary antibodies were Dylight-
488-, Dylight-549,- and Dylight-649-conjugated antibodies,
with a universal nuclear marker, 4′,6-diamidino-2-phenylindole
(DAPI, all from Jackson Immunoresearch). MUC samples were
incubated with primary antibodies overnight at 4◦C, followed by
secondary antibodies incubation for 2–3 h at room temperature.
MUCs were observed using a Leica epifluorescence microscope
and images were captured using a QImaging monochrome cool
CCD camera.
Nuclear Extraction and Western Blotting
The nuclear extracts from the control and treated MUCs were
harvested using a Chemicon Nuclear Extraction Kit (Millipore)
according to the manufacturer’s protocol. Western blotting was
used to study the protein expression in the control and treated
MUCs (n = 3). Antibodies used in western blotting included
monoclonal goat anti-E-cadherin (E-cad, 1:100; Santa Cruz),
polyclonal rabbit anti-Myosin VI (1:100; Sigma), monoclonal
mouse anti-Myosin VIIa (1:100; DSHB), polyclonal rabbit
anti-Pou4f3 (1:200; Sigma), monoclonal mouse anti-DNMT1
(1:100; Epigentek), and mouse anti-GAPDH (1:200; Thermo
Scientific). Secondary antibodies included donkey anti-goat
HRP-conjugated, donkey anti-rabbit HRP-conjugated, donkey
anti-mouse HRP-conjugated antibodies, and HRP standard
protein (all from Bio-Rad). Clarity
TM
ECL Western Blotting
Substrate (Bio-Rad) was applied to blotting membranes, and
images were captured by a ChemiDoc-It R© 2 imaging system. To
quantify protein expression changes, ImageJ (NIH) was used to
measure the band density of studied proteins. The protein band
density of control MUCs was normalized to 1, and the protein
density of treated MUCs was determined by its relative intensity
to that of control MUCs.
Genomic Methylated DNA Quantification
Genomic methylated DNA was examined using a MethylFlash
Methylated DNA Quantification Kit (Epigentek). The positive
control of methylated DNA was artificially synthesized and
provided with the kit by the manufacturer, in which 50%
DNA has been methylated at 5-cytosine. A standard curve
was generated by diluting the positive control to a series
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of concentrations at 0, 0.5, 1, 2, 5, and 10 µg/ml following
the manufacturer’s protocol. The relative fluorescence unite
(RFU) was read at 530EX/590EM nm using a Gemini EM
fluorescence microplate reader (Molecular Devices). The
genomic methylation level was quantified by the percentage
of 5-methylcytosin (5-mC%), which was determined as(
sample RFU-negative control RFU
)
÷ amount of input
sample DNA (ng)(
positive control RFU-negative control RFU
)
× 2 ÷ amount
of input positive control (ng)
× 100% (n = 4). The genomic methylation inhibition was
calculated as:
5-mC%(experiment)− 5−mC%(control)
5-mC%(experiment)
× 100%.
A two-tailed Student’s t-test was used to compare the 5-mC% of
the control and treatment groups.
DNMT Activity Assay
DNMT activity was estimated in the nuclear extracts
of the control and treatment group using an EpiQuik
DNMT Activity/Inhibition Assay Ultra Kit—Fluorometric
(Epigentek) according to the manufacturer’s protocol.
Gemini EM fluorescence microplate reader was used to
read the relative fluorescence unit (RFU) at 530EX/590EM
nm (n = 4). DNMT activity (RFU/h/µg) was determined as:
(Sample−Blank RFU)
Protein amount (µg) ×Reaction time (h)
. The DNMT inhibition
was calculated as:
Treated sample RFU−Blank RFU
Control sample RFU−Blank RFU
× 100%.
Mechanotransduction Channel Permeation
Assay
Functional sensory hair cells usually possess potent
mechanosensory transduction channels to convert mechanical
movements into cellular activities. A styryl pyridinium dye
N-(3-triethylammoniumpropyl)-4-[4-(dibutylamino)styryl]
pyridiniumdibromide, FM1-43 has been used to evaluate
functional mechanosensory transduction channels in
development and stem cell regeneration (Geleoc and
Holt, 2003; Hu and Corwin, 2007). In this study, FM1-43
(Invitrogen) was used as a probe to investigate the existence of
mechanotransduction channels. In an initial optical assay for
mechanotransduction channel function, the control and treated
MUCs were incubated in DMEM/F12 containing 5 µM FM1-43
for 5–30 s at room temperature and rinsed by DMEM/F12 for
3 times (n = 5). Samples were immediately examined under a
Leica epifluorescence microscope and imaged using a QImaging
monochrome cool CCD camera. In quantitative study, MUCs
showing FM1-43 label around nuclei were quantified for cell
counting (n= 5).
RESULTS
Viability of MUCs Following 5-Aza
Treatment
Calcein AM, propidium iodide (PI), and Hoechst 33342 were
used to determine the viability of MUCs. After treatment of
5-azacytidine (5-aza) for 48 h, viable MUCs were stained with
calcein AM showing green (Figure 1A; n = 5). Approximately
81.75 ± 1.72%, 74.86 ± 3.48%, 73.52 ± 2.50%, 68.21 ± 4.41%,
62.48± 2.19%, and 56.38± 4.26%MUCs were labeled by calcein
AM when exposed to 0 (control), 20, 40, 80, 160, and 320
µM 5-aza respectively (Figure 1B; n = 5). One-way analysis of
variance (ANOVA) showed significant difference among these
groups (P < 0.05). Comparing with control MUCs, Tukey post-
hoc test indicated that 80, 160, and 320 µM 5-aza treatments
caused a significant reduction in the number of viable MUCs (P
< 0.05), whereas 20 and 40 µM 5-aza did not have significant
effects (P > 0.05). The dead MUCs were labeled by PI showing
red (Figure 1A). Quantitative analysis showed that 5.56± 1.52%,
11.23 ± 2.53%, 16.89 ± 1.01%, 23.27 ± 2.89%, 29.18 ± 3.07%,
and 35.08 ± 4.57% MUCs were stained by PI in 0 (control), 20,
40, 80, 160, and 320 µM 5-aza, respectively (Figure 1B), which
was significantly different (P < 0.05, ANOVA). Tukey post-hoc
test suggested a significantly increased number of dead MUCs in
80, 160, and 320 µM 5-aza groups (P < 0.05). Neither 20 nor 40
µM5-aza caused obvious cell death (P> 0.05). Therefore, 40µM
5-aza was selected for further studies.
Expression of Prosensory Genes Following
5-Aza Treatment
Reverse transcription PCR (RT-PCR) showed that expression of
some prosensory genes including Sox2, Bmp4, Lfng, Prox1, and
P27kip1 was significantly higher in the treatment group than those
in the control group (Figure 2A). Quantitative PCR showed 3.53
± 0.11, 4.49 ± 0.64, 10.86 ± 0.27, 7.17 ± 0.17, and 5.36 ± 0.17
fold of up-regulation of Bmp4, Sox2, Prox1, Lfng and P27kip1
respectively, which was statistically significant (Figure 2D; P <
0.05, Student’s t-test). Other studied prosensory genes did not
show significant expression changes (≤2-fold), including Jag1
(1.22 ± 0.04 fold), Hes1 (1.18 ± 0.04 fold), Dlx5 (0.55 ± 0.02
fold), and Isl1 (1.03± 0.03 fold).
Expression of Sensory Hair Cell Markers
and Differentiation of Functional Hair
Cell-Like Cells
In response to 40 µM 5-aza treatment for 5 days, expression
of epithelial genes Cdh1 and Krt8 was increased comparing
with control MUCs (Figure 2B). Quantitative PCR showed that
Cdh1 and Krt8 had 2.50 ± 0.35 and 5.50 ± 0.45 fold of up-
regulation after treatment respectively (Figure 2E). To study
whether treated MUCs differentiated into hair cells, expression
of hair cell genes was investigated using RT-PCR and quantitative
PCR. After treatment, RT-PCR suggested increased expression of
hair cell genes including Atoh1, Myo7a, Myo6, Espn, and Pou4f3
(Figure 2C). In quantitative PCR, normalized relative expression
of Atoh1, Myo7a, Myo6, Espn, and Pou4f3 was ∼3.74 ± 1.27,
3.10 ± 0.19, 2.89 ± 0.07, 4.14 ± 0.07, 274.42 ± 45.49 fold higher
than those of control MUCs respectively (Figure 2F). Student’s
t-test indicated significant difference between the control and
treatment groups (P < 0.05).
Immunofluorescence indicated that control MUCs did not
exhibit expression of E-cadherin (E-cad, encoded by Cdh1), pan-
cytokeratin 26 (PCK26, encoded by Krts including Krt8), Math1
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FIGURE 1 | Viability of MUCs following 5-aza treatment. (A) Calcein and PI were used to determine the viability of MUCs treated with 0, 20, 40, 80, 160, and 320
µM 5-aza (n = 5). Hoechst 33,342 was used to label all nuclei (blue), calcein for viable cells (green), PI for dead cells (red, double labeled with Hoechst 33,342 thus
showing in pink, arrows). Scale bar, 100 µm. (B) The percentage of viable cells decreased with the 5-aza concentration, whereas percentage of dead cells increased,
which was significantly different (P < 0.05 ANOVA). Tukey post-hoc test suggested that 20–40 µM 5-aza did not cause obvious cell death (P > 0.05).
(encoded by Atoh1), Myosin VI, or Pou4f3, but had weakMyosin
VIIa expression. After treatment, immunofluorescence showed
that treated MUCs significantly increased protein expression
of these sensory hair cell markers (Figure 3A). Additionally,
western blotting revealed remarkably increased expression of
E-cadherin, Myosin VIIa, Myosin VI, and Pou4f3 in treated
MUCs (Figure 3B). To quantify protein expression changes,
we measured protein band density using ImageJ, with protein
band density of control MUCs normalized to 1. We found that
the relative protein densities in treated MUCs were GAPDH
97.71 ± 2.33%, E-cadherin 155.71 ± 9.86%, Myosin VIIa 238.41
± 6.42%, Myosin VI 176.33 ± 12.96%, and Pou4f3 157.51 ±
7.06% (Figure 3B). These protein studies indicated that 5-aza was
able to stimulate MUCs to increase protein expression of hair
cell markers. To further ascertain sensory hair cell generation,
treated MUCs were double labeled by epithelial hair cell markers,
including Myosin VIIa+Myosin VI and Myosin VIIa+ Pou4f3
(Figure 3C). Quantitative study showed that 29.04 ± 4.65% of
treatedMUCs were Myosin VIIa andMyosin VI positive (n= 5).
Additionally, the hair bundle-like structures were labeled by
anti-Espin antibody (encoded by Espn; Figure 3C). To examine
whether hair cell-like cells are newly-generated cells, anti-PCNA
antibodies were used to co-label with anti-Myosin VI antibodies
and the result indicated that some treated MUCs were both
PCNA and Myosin VI positive (Figure 3D), suggesting that
hair cell-like cells were newly-generated cells. These results
demonstrated that treatedMUCs expressed hair cell proteins and
the hair bundle specific protein Espin, indicating that 5aza was
able to stimulate MUCs to adopt a hair cell-like cell fate.
Because we found expression of hair cell genes and
proteins in treated MUCs, we performed a mechanosensory
transduction permeation assay to investigate whether treated
MUCs possessed mechanosensory transduction channels, which
are specifically shown in sensory hair cells. FM1-43 has
been reported to be able to fill into the cytoplasm of hair
cells with functional mechanosensory transduction channels
when hair cells are briefly exposed to this compound (Geleoc
and Holt, 2003). Additionally, FM1-43 permeation assay
has been used to determine mechanosensory transduction
channels in stem cell studies (Hu and Corwin, 2007). In
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FIGURE 2 | Gene expression changes following 5-aza treatment. (A) Following 5-aza treatment, RT-PCR showed increased expression in Sox2, Bmp4, Lfng,
Prox1, and P27kip1, whereas no obvious change in Jag1, Hes1, Isl1, and Dlx5. (B) RT-PCR showed that MUCs up-regulated expression of epithelial genes Cdh1 and
Krt18 following 5-aza treatment. (C) RT-PCR showed that expression of hair cell genes Atoh1, Myo7a, Myo6, Espn, and Pou4f3 was up-regulated following 5-aza
treatment. (D) Quantification PCR showed ∼3.53 ± 0.11, 5.36 ± 0.17, 10.86 ± 0.27, 7.17 ± 0.17, and 4.49 ± 0.64 fold of up-regulation of Bmp4, P27kip1, Prox1,
Lfng, and Sox2, respectively after 5-aza treatment (P < 0.05, Student t-test; n = 5). (E) Quantification PCR showed normalized relative expression of Cdh1 and Krt18
of treated MUCs were 2.50 ± 0.35 and 5.50 ± 0.45 fold higher than those of control MUCs, which is statistically significant (P < 0.05; Student’s t-test; n = 5). (F)
Quantitative study indicated that normalized relative expression values of Atoh1, Myo7a, Myo6, Espn, and Pou4f3 were ∼5.74 ± 1.27, 3.10 ± 0.19, 1.89 ± 0.07,
4.14 ± 0.07, 274.42 ± 45.49 fold higher than those of control MUCs respectively, and statistical analysis showed significant difference (P < 0.05; Student’s t-test;
n = 5). * Indicates significant difference comparing with the control group.
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FIGURE 3 | Hair cell protein expression changes following 5-aza treatment. (A) Immunofluorescence showed up-regulated expression of epithelial hair cell
markers E-cad, PCK26, Myosin VIIa, Myosin VI, Math1, and Pou4f3 in treated MUCs (Scale bar 100 µm). (B) Western blotting showed significant increased
expression of Myosin VIIa and Myosin VI, and slightly up-regulation of E-cad and Pou4f3 in treated MUCs. (C) Multiple-labeling immunofluorescence showed that
newly-generated hair cell-like cells were double-labeled with Myosin VIIa and Myosin VI, Myosin VIIa and Pou4f3, and Myosin VIIa and Espin (scale bar 50 µm). (D)
Hair cell-like cells were PCNA and Myosin VI positive, suggesting that these cells were newly-generated cells (scale bar 50 µm). (E) In initial optical assay using
FM1-43 permeation test, control MUCs did not show FM1-43 signal after 30 s incubation. In treated MUCs, ∼30% of treated MUCs were filled with FM1-43 when
they were exposed to FM1-43 for 10 s at room temperature (scale bar 100 µm).
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 August 2016 | Volume 10 | Article 185
Zhou and Hu Inner Ear Stem Cell Demethylation
an initial optical assay, we did not observe FM1-43 positive
cells in control MUCs after 30 s of incubation (Figure 3E).
In treated MUCs, ∼30% of treated MUCs were filled with
FM1-43 when they were exposed to FM1-43 for 10 s at
room temperature (Figure 3E; n= 5). This study revealed that
treated MUCs were permeable to FM1-43, suggesting that
treated MUCs may possess potential FM1-43-permeation related
mechanotransduction channels that are shown in functional
sensory hair cells.
Genomic Demethylation, DNMT
Expression, and Enzyme Activity Assay
To study whether 5-aza treatment was related to the generation
of hair cell-like cells, we performed a genomic methylated
DNA quantification assay to determine the genomic methylation
level. The relative quantification of genomic methylated DNA
(5-mC%) of control MUCs was 0.35 ± 0.04%. After 5 days
of 5-aza treatment, the relative 5-mC% of treated MUCs
decreased to 0.25 ± 0.04% (Figure 4A). Therefore, the genomic
methylation inhibition showed 28.57% [(0.35 − 0.25%)/0.35 ×
100%] decrease in genomicmethylation level in response to 5-aza
treatment. The statistical analysis indicated significant difference
of relative 5-mC% between the control and treatment groups
(P < 0.05, Student’s t-test).
RT-PCR and quantitative PCR were performed to exam
gene expression changes of DNMTs in the control and
5-aza-treated MUCs. After 5-aza treatment, expression of
maintenance DNA methylatransferase Dnmt1 and de novo DNA
methyltransferase Dnmt3a was not significant changed in RT-
PCR and quantitative PCR (Figures 4B,D). But expression of
de novo DNA methyltransferase Dnmt3b was decreased in RT-
PCR (Figure 4D), which was confirmed by quantitative PCR
(0.52 ± 0.01 fold down-regulation; P < 0.05, Student’s t-test;
Figure 4B).
To study whether 5-aza affected the activity of DNMT, the
DNMT activity assay was applied. The activity of DNMT in the
control group was 70.33 ± 5.24 RFU/h/µg, but it reduced to
59.47± 3.87 RFU/h/µg after treatment (Figure 4C). The DNMT
inhibition assay suggested that there was an approximately
15.37 ± 0.09% inhibition effect on DNMT activity after 5-
aza treatment, which was statistically significant (P < 0.05,
Student’s t-test).
In the protein assay, both western blotting and immuno-
fluorescence showed down-regulated expression of DNMT1
after treatment (Figures 4E,F). The immunofluorescence study
indicated that DNMT1 expression was significantly decreased
after treatment. Additionally, expression of DNMT1 was mainly
showed in the cytoplasm of controlMUCs, whereas its expression
translocated to the nuclei of treated MUCs (Figure 4F). Overall,
the DNMT1 expression change of treated MUCs showed in the
protein level but not in the gene level.
Mechanism of Sensory Hair Cell-Like Cell
Differentiation Following 5-Aza Treatment
It is known that 5-aza is able to induce genomic demethylation
to regulate gene expression in some cell lines (Schneider-Stock
et al., 2005; Song et al., 2014); however, it remains unclear
whether 5-aza is able to affect the methylation level and plays
a role in inducing expression of sensory hair cell genes in
tissue specific stem/progenitor cell model MUCs. To address
this question and also to further study the relationship between
expression of sensory hair cell markers and 5-aza treatment,
nested methylation specific PCR (nested-MSP) was performed
to examine methylation pattern changes in the promoter region
of sensory hair cell genes Atoh1, Pou4f3, and Cdh1 (Figure 4G).
The same amount of bisulfite converted gDNA of control and
treated MUCs was used as templates in nested-MSP, and the
primers were designed to specifically target to the CpG island
in the promoter region of studied genes. According to the
electrophoresis analysis of nested-MSP, the normalized amount
of unmethylated Cdh1 of the control and treatment group were
similar, whereas the amount ofmethylatedCdh1 of treatedMUCs
was slightly lower than that of control MUCs. In the study of
nested-MSP of hair cell genes, Atoh1 was highly methylated in
control MUCs. After treatment, the amount of methylated Atoh1
was significantly decreased, whereas the amount of unmethylated
Atoh1 was remarkably increased. Moreover, treated MUC
exhibited an obviously higher expression of unmethylated Atoh1
than methylated Atoh1. Another hair cell gene Pou4f3 exhibited
a significant high amount of methylated expression in control
MUCs, whereas the amount of unmethylated Pou4f3 was scarce.
After treatment, expression of methylated Pou4f3was completely
shut down, whereas the amount of unmethylated Pou4f3
was significantly increased. The nested-MSP data suggested
that 5-aza caused demethylation of Atoh1 in the promoter
region, which may contribute to increased expression of
Atoh1 gene.
To further examine the methylation level of studied genes in
treated MUCs, methylated DNA immunoprecipitation (MeDIP)
and quantitative PCR were performed (n = 3). Genomic DNA
of the control and treated MUCs was randomly broken into
DNA fragments using sonication. The same amount of DNA
fragments was added to immunoprecipitation reaction, followed
by quantitative PCR to analyze the quantity of methylated Cdh1,
methylated Atoh1 and methylated Pou4f3. The primers were
designed to specifically target to the promoter region of studied
genes. In control MUCs, the Cq value of methylated Cdh1 was
27.35± 0.01, whereas it increased to 27.52± 0.46 after treatment,
which was not statistically significant (P > 0.05, Student t-test).
The Cq value of methylated Atoh1 in control MUCs was 35.38
± 0.38, which was increased to 37.33 ± 0.07 after treatment
(P < 0.05, Student t-test). The Cq values of methylated Pou4f3
were 23.00 ± 0.07 and 24.84 ± 0.17 in control and treatment
group respectively (P < 0.05, Student’s t-test). Compared to
control MUCs (normalized to 1), MeDIP quantitative analysis
using the 2−11Cq (Livak) Method showed 0.89 ± 0.01 fold of
methylated Cdh1, 0.26 ± 0.07 fold of methylated Atoh1 and 0.28
± 0.07 fold of methylated Pou4f3 in treated MUCs (Figure 4H).
These studies suggested that decreased amount of methylated
Atoh1 and Pou4f3 may lead to up-regulated hair cell gene
expression, and that increased expression of hair cell gene Atoh1
and Pou4f3 was likely caused by demethylation of their promoter
regions.
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FIGURE 4 | Genomic demethylation, DNMT1 protein down-regulation and DNMT activity suppression. (A) 5-aza treatment decreased genomic 5-mC%
from 0.35 ± 0.04% (control MUCs) to 0.25 ± 0.04% (treated MUCs), which was ∼28.57% decrease (P < 0.05, Student’s t-test; n = 5). (B) Quantitative PCR showed
approximately 1.29 ± 0.26 fold up-regulated Dnmt1expression, 0.80 ± 0.24 fold down-regulated Dnmt3a expression, and 0.52 ± 0.01 fold down-regulated Dnmt3b
expression. (C) DNMT activity assay revealed the activity of DNMT decreased from 70.33 ± 5.24 RFU/h/µg (control MUCs) to 59.47 ± 3.87 RFU/h/µg (treated MUCs)
after 5-aza treatment, which caused 15.37 ± 0.09% inhibition of DNMT activity (P < 0.05, Student t-test; n = 5). (D) RT-PCR suggested no obviously change of
Dnmt1 and Dnmt3a, but down-regulation of Dnmt3b in treated MUCs. (E) Western blotting showed significant decreased expression of DNMT1 in treated MUCs. (F)
Immunofluorescence showed down-regulated expression of DNMT1 in treated MUCs. The DNMT1 expression was restricted to the nuclei after treatment (scale bar
100 µm). (G) Nested-MSP targeting the CpG island in promoter region showed that the methylation/unmethylation ratio of studied sensory hair cell markers was
significantly decreased after 5-aza treatment (M, methylated DNA; U, unmethylated DNA). (H) Compared to control MUCs (normalized to 1), MeDIP-quantitative PCR
showed 0.89 ± 0.01-fold of methylated Cdh1, 0.26 ± 0.07 fold of methylated Atoh1 and 0.28 ± 0.07 fold of methylated Pou4f3 expression in treated MUCs.
* Indicates significant difference comparing with the control group.
DISCUSSION
In this study, 5-aza was used to treat mouse utricle sensory
epithelia-derived progenitor cell MUC. After the treatment,
expression of prosensory genes, epithelial genes and hair
cell genes was up-regulated. We found that 5-aza treatment
caused increased protein expression of E-cadherin, Myosin VIIa,
Myosin VI, and Pou4f3. FM1-43 permeation assay revealed
that treated MUCs possessed the permeability of functional
mechanotransduction channels. 5-aza significantly decreased
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DNMT1 protein expression and DNMT activity, by which
the genome of MUCs underwent a remarkable demethylation
process. Genomic methylation assays revealed that increased
expression of sensory hair cell markers Atoh1 and Pou4f3 were
likely resulted from DNA demethylation in their promoter
regions.
5-aza is a DNMT inhibitor, which causes DNA demethylation
by blocking DNMTs. Our study demonstrated that treated
MUCs showed no obviously gene expression change
of maintenance methyltransferase Dnmt1 and de novo
methyltransferase Dnmt3a, but down-regulated expression
of de novo methyltransferase Dnmt3b. However, the protein
expression of DNMT1 was significantly decreased, and DNMT
activity was remarkably reduced following 5-aza treatment.
Down-regulated DNMT1 protein expression and decreased
DNMT activity may contribute to the demethylation of MUC
genome. Our result is consistent with previous studies, which
suggested that DNA demethylation was caused by down-
regulated Dnmt gene and protein expression in cervical cancer,
prostate cancer and acute leukemia cell lines (Chen et al.,
2003; Walton et al., 2008; Lund et al., 2014). Additionally,
our immunofluorescence study showed that DNMT1 mainly
expressed in the cytoplasm of control MUCs, whereas its
expression was reduced and translocated to the nuclei of treated
MUCs. It has been reported that the intracellular localization of
DNMT1 is various and is dependent on cell type, developmental
stage, and pathological condition (Doherty et al., 2002; Ratnam
et al., 2002; Lundberg et al., 2009; Desplats et al., 2011). In the
current observation, DNMT1 translocation was observed in
treated MUCs, but the mechanism of intracellular translocation
is still obscure, which needs further investigation in our future
studies. Overall, down-regulated DNMT1 protein expression
and decreased DNMT activity may cause a remarkable
demethylation in the genome of 5-aza-treated MUCs, which
may contribute to the gene expression changes as discussed
below.
Recent studies suggested that DNA demethylation may play
an important role in stem cell reprogramming (Bagci and Fisher,
2013; Wongtrakoongate, 2015). For example, a differentiated cell
line, normal adult basal prostatic epithelial (E-PZ) cells, could
be reprogrammed and dedifferentiated into induced pluripotent
stem cells by forced expression of embryonic pluripotent genes
including Sox2,Oct4, and SSEA-3 (Zhao et al., 2013). The authors
studied the methylation level of pluripotent genes and prostatic
epithelial genes and found that during prostate differentiation,
the methylation level of pluripotent genes elevated, whereas the
methylation level of prostatic epithelial genes reduced, suggesting
that DNA methylation plays an important role in stem cell
differentiation (Zhao et al., 2013). In the present study using
a tissue specific progenitor cell line MUC, we found that
DNA methylation level was related to expression of prosensory
genes such as Sox2 and Lfng. HMG-box transcription factor
Sox2 is essential for sensory progenitor development in the
mammalian inner ear including the differentiation of hair cell
precursors. Sox2 positive prosensory cells acquired an active
expression of Atoh1, a transcription factor critical for hair
cell differentiation, therefore determining the cell fate as hair
cells (Locher et al., 2013). Overexpression of Sox2 in mouse
otocyst induced sensory region specification, which subsequently
stimulated prosensory cell differentiation and hair cell formation
(Pan et al., 2013). It was reported that O-fucosylpeptide 3-beta-
N-acetylglucosaminyltransferase, Lfng, was expressed in chicken
otocysts and involved in the development of sensory organ in the
inner ear development (Cole et al., 2000; Pujades et al., 2006).
In the present study, 5-aza-induced DNA demethylation is likely
to up-regulate expression of prosensory genes Sox2 and Lfng,
which may be involved in guiding MUCs along a development
program toward hair cell formation. Additionally, we observed
other prosensory genes, including Bmp4 and P27kip1, changed
their expression following treatment, suggesting that these
prosensory genes may also be involve in the differentiation
of MUCs.
In this study, control MUCs did not express epithelial genes
Cdh1, Krt8, or hair cell gene Myo6, Atoh1, and Pou4f3. After
5-aza treatment, expression of these studied epithelial sensory
hair cell genes was significantly increased. Protein expression
of these epithelial sensory hair cell markers was elevated in
treated MUCs in immunofluorescence and western blotting.
FM1-43 permeation assays indicated that treated MUCs were
permeable to FM1-43, which suggested that treated MUCs
may possess some properties of mechanotransduction channels
of sensory hair cells. Furthermore, the genomic methylation
level of treated MUCs was significantly decreased. Expression
of DNMT1 protein and the activity of DNMTs were down-
regulated following 5-aza treatment. To understand whether
DNA methylation level influences hair cell gene expression,
MSP, and MeDIP using primers targeting the promoter regions
of hair cell genes were performed. The results revealed that
relative expression of methylated Cdh1, Atoh1, and Pou4f3
was decreased and unmethylation of the promoter region of
these genes was obviously increased after 5-aza treatment,
which likely led to demethylation of the promoter region of
studied genes, subsequently stimulated MUCs to upregulate
expression of sensory hair cell genes and proteins, and finally
contributed to differentiation of MUCs into hair cell-like
cells. Our observation suggested that 5-aza treatment may be
an approach to affect the methylation level of MUCs, and
subsequently stimulates MUCs to differentiate into functional
hair cell-like cells.
Compared to 5-aza-CdR that was used in our previous report
(Zhou and Hu, 2015), 5-aza seems to have better effects on
sensory hair cell induction. In comparison of relative gene
expression, majority of hair cell genes showed significant changes
after 5-aza treatment. For instance, Atoh1, Espn, and Pou4f3
had 3.74 ± 1.27, 4.14 ± 0.07, 274.42 ± 45.49 fold increase
after 5-aza treatment, but they did not show significant changes
after 5-aza-CdR treatment. Further, 5-aza treatment stimulated
hair cell protein expression including Myosin VIIa, Myosin
VI, Pou4f3, and Math1, but 5-aza-CdR treatment did not
cause obvious hair cell protein expression changes. Although
5-aza may cause adverse effects; however, no serious clinical
complications and death attribute to 5-aza. Therefore, 5-aza has
a preferable safety data and it has been approved by The Food
and Drug Administration (FDA) for clinical therapy since 2004
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(Kaminskas et al., 2005). Based on these data, 5-aza treatment
seems to exert a better role in inducing hair cell generation
fromMUCs.
In summary, the DNMT inhibitor 5-aza caused DNA
demethylation in the entire genome of MUCs to induce cell
lineage specification. In the treatment group, gene and protein
expression of sensory hair cell markers was remarkably increased.
The FM1-43 permeability assay indicated that treated MUCs
may possess some properties of mechanosensory transduction
channels, suggesting that treated MUCs had differentiated into
hair cell-like cells. Nested-MSP and MeDIP-quantitative PCR
revealed that up-regulation of sensory hair cell genes was
likely caused by demethylation of the promoter region of these
genes. Our study demonstrated a novel epigenetic approach
in stem cell biology, which could induce tissue specific inner
ear progenitors to differentiate into functional sensory hair
cell-like cells. In the meantime, it opens avenues to develop
strategies to guide tissue specific stem/progenitor cells to become
functional cells without altering DNA sequence, which is
fundamental to the design of future clinical trials involving
human cells.
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